Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Melvin Klegerman
University of Texas Hlth Sci Ctr Houston, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Zymo Pharmaceuticals, LLC.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Klegerman holds equity in Zymo Pharmaceuticals, LLC. The company is a private, for-profit company whose business focuses on the development of echogenic liposomes (ELIP) to be a platform for both diagnostic and therapeutic applications. This research project utilizes the ELIP technology in several novel treatment strategies to try and inhibit or slow the progression of atherosclerosis. The research involves the related technology.
Echogenic Targeted Liposomes: Transfection/Drug Delivery
PROJECT NARRATIVE This proposal seeks to develop a carrier (echogenic immunoliposomes) with novel ultrasound delivery methodologies that have the ability to incorporate therapeutics and enhance delivery to stabilize atherosclerotic beds at the time of intervention.
Filed on October 27, 2017.
Tell us what you know about Melvin Klegerman's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.